Royal Bank of Canada
NVOS

Royal Bank of Canada’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

Royal Bank of Canada’s Portfolio NVOS Stock Details NVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,495
Closed -$2K – 7444
2024
Q3 		$2K Sell
7,495
-33
-0.4% -$15 ﹤0.01% 6679
2024
Q2 		$6K Hold
7,528
– – ﹤0.01% 6514
2024
Q1 		$4K Hold
7,528
– – ﹤0.01% 6555
2023
Q4 		$6K Buy
7,528
+2
+0% +$4 ﹤0.01% 6635
2023
Q3 		$22K Sell
7,526
-113
-1% -$206 ﹤0.01% 6155
2023
Q2 		$11K Buy
7,639
+145
+2% +$198 ﹤0.01% 6458
2023
Q1 		$9K Sell
7,494
-320
-4% -$425 ﹤0.01% 6384
2022
Q4 		$16K Sell
7,814
-16
-0.2% -$55 ﹤0.01% 6392
2022
Q3 		$82K Sell
7,830
-859
-10% -$14K ﹤0.01% 5449
2022
Q2 		$162K Hold
8,689
– – ﹤0.01% 4967
2022
Q1 		$200K Hold
8,689
– – ﹤0.01% 5089
2021
Q4 		$121K Hold
8,689
– – ﹤0.01% 5790
2021
Q3 		$160K Hold
8,689
– – ﹤0.01% 5363
2021
Q2 		$218K Buy
8,689
+144
+2% +$3.59K ﹤0.01% 5006
2021
Q1 		$299K Buy
+8,545
New +$356K ﹤0.01% 4621

Other funds holding NVOS

AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

Royal Bank of Canada's NVOS Position: Q4 2024 in Review

Royal Bank of Canada sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q4 2024, closing a stake of 7,495 shares — an estimated $2K sold.

Royal Bank of Canada first reported a position in NVOS in Q1 2021 and held it in 15 quarters. The position peaked at $299K in Q1 2021. 1 fund tracked by Wall St. Rank holds NVOS as of Q4 2024.

  • Royal Bank of Canada reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 7,495 Novo Integrated Sciences, Inc. Common Stock shares in Q4 2024, an estimated $2K.
  • Royal Bank of Canada first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q1 2021 and held it in 15 quarters.
  • Royal Bank of Canada's Novo Integrated Sciences, Inc. Common Stock position peaked at $299K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q4 2024.

Based on Royal Bank of Canada's 13F filing for Q4 2024, filed 14 Feb 2025.